Teva Pharmaceutical Industries Ltd. (TEVA)
30.18
+0.38
(+1.26%)
USD |
NYSE |
Dec 11, 16:00
30.19
+0.02
(+0.05%)
After-Hours: 20:00
Teva Pharmaceutical Industries EPS Diluted (Quarterly): 0.3737 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Novo Nordisk A/S | 0.7044 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 436.03M |
| Revenue (Quarterly) | 4.492B |
| Total Expenses (Quarterly) | 4.057B |
| Enterprise Value | 49.06B |
| Gross Profit Margin (Quarterly) | 51.33% |
| Profit Margin (Quarterly) | 9.71% |
| Earnings Yield | 2.03% |
| Operating Earnings Yield | 10.33% |
| Normalized Earnings Yield | 5.505 |